Top Markets
Coin of the day
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Rang în acțiuni #38984
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Preț acțiune
$0.0601
Capitalizare de piață
$699.79K
Schimbare (1 zi)
-14.14%
Schimbare (1 an)
0.17%
Țară
US
Tranzacționează Hepion Pharmaceuticals, Inc. (HEPA)

Categorie

Istoricul spliturilor pentru Hepion Pharmaceuticals, Inc. (HEPA)
Acțiunea Hepion Pharmaceuticals, Inc. (simbol: HEPA) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 14, 2026.
O acțiune HEPA cumpărată înainte de Aug 14, 2026 este echivalentă astăzi cu 0 acțiuni HEPA.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE